---
title: 'Evaluation of all-cause mortality and cardiovascular safety in patients receiving
  chimeric antigen receptor T cell therapy: aÂ prospective cohort study'
date: '2024-03-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38544797/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240328180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Assessment of cardiovascular risk is critical for patients
  with cancer. Previous retrospective studies suggest potential cardiotoxicity of
  CAR T cell therapies. We aimed to prospectively assess cardiotoxicity and the predictive
  value of cardiac biomarkers and classical risk factors (age, cardiac function, diabetes,
  arterial hypertension, smoking) for cardiac events and all-cause mortality ...'
disable_comments: true
---
BACKGROUND: Assessment of cardiovascular risk is critical for patients with cancer. Previous retrospective studies suggest potential cardiotoxicity of CAR T cell therapies. We aimed to prospectively assess cardiotoxicity and the predictive value of cardiac biomarkers and classical risk factors (age, cardiac function, diabetes, arterial hypertension, smoking) for cardiac events and all-cause mortality ...